Sverrir Harðarson

951 total citations
23 papers, 643 citations indexed

About

Sverrir Harðarson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Sverrir Harðarson has authored 23 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Sverrir Harðarson's work include Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Renal and related cancers (5 papers). Sverrir Harðarson is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Renal and related cancers (5 papers). Sverrir Harðarson collaborates with scholars based in Iceland, United States and Denmark. Sverrir Harðarson's co-authors include Guðmundur Einarsson, Tómas Guðbjartsson, Vigdís Pétursdóttir, Ásgeir Thoroddsen, Jónas Magnússon, Eiríkur Jónsson, Martin I. Sigurðsson, Cyril Fisher, Mark E. Smith and Laufey T. Ámundadóttir and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and Ophthalmology.

In The Last Decade

Sverrir Harðarson

23 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sverrir Harðarson Iceland 13 408 328 143 117 109 23 643
Walid A. Mourad Saudi Arabia 17 244 0.6× 246 0.8× 229 1.6× 121 1.0× 86 0.8× 42 742
Stephen Rohan United States 15 509 1.2× 459 1.4× 133 0.9× 177 1.5× 268 2.5× 28 879
Stela Bulimbašić Croatia 17 688 1.7× 526 1.6× 85 0.6× 179 1.5× 205 1.9× 57 926
Chao Cai China 17 265 0.6× 261 0.8× 176 1.2× 136 1.2× 135 1.2× 48 768
Masayuki Hagiwara Japan 17 265 0.6× 311 0.9× 299 2.1× 280 2.4× 126 1.2× 58 819
Wen Cai China 16 209 0.5× 122 0.4× 262 1.8× 89 0.8× 106 1.0× 55 565
J P Basuyau France 15 142 0.3× 107 0.3× 226 1.6× 91 0.8× 136 1.2× 33 618
Yao Liang China 15 282 0.7× 144 0.4× 330 2.3× 150 1.3× 174 1.6× 40 703
Claudia Parolini Italy 14 149 0.4× 153 0.5× 136 1.0× 67 0.6× 49 0.4× 18 465
Anita Deshpande United States 8 644 1.6× 534 1.6× 173 1.2× 193 1.6× 290 2.7× 11 833

Countries citing papers authored by Sverrir Harðarson

Since Specialization
Citations

This map shows the geographic impact of Sverrir Harðarson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sverrir Harðarson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sverrir Harðarson more than expected).

Fields of papers citing papers by Sverrir Harðarson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sverrir Harðarson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sverrir Harðarson. The network helps show where Sverrir Harðarson may publish in the future.

Co-authorship network of co-authors of Sverrir Harðarson

This figure shows the co-authorship network connecting the top 25 collaborators of Sverrir Harðarson. A scholar is included among the top collaborators of Sverrir Harðarson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sverrir Harðarson. Sverrir Harðarson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cariglia, Nick, et al.. (2020). Trefjabólgusepi í smágirni – sjúkratilfelli. Læknablaðið. 2020(708). 349–351. 1 indexed citations
2.
Ingimarsson, Johann P., Martin I. Sigurðsson, Sverrir Harðarson, et al.. (2014). The impact of tumour size on the probability of synchronous metastasis and survival in renal cell carcinoma patients: a population-based study. BMC Urology. 14(1). 5–5. 14 indexed citations
3.
Valdimarsson, Helgi, et al.. (2013). Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy. Apmis. 121(9). 890–897. 4 indexed citations
4.
Harðarson, Sverrir, Vigdís Pétursdóttir, Eiríkur Jónsson, et al.. (2012). Synchronous Pulmonary Metastases from Renal Cell Carcinoma — A Whole Nation Study on Prevalence and Potential Resectability. Scandinavian Journal of Surgery. 101(3). 160–165. 12 indexed citations
5.
Andrésdóttir, Margrét B., et al.. (2011). Acute flank pain syndrome: a common presentation of acute renal failure in young men in Iceland. Læknablaðið. 97(4). 215–221. 1 indexed citations
6.
Harðarson, Sverrir, Vigdís Pétursdóttir, Eiríkur Jónsson, et al.. (2011). Incidental Detection of Renal Cell Carcinoma is an Independent Prognostic Marker: Results of a Long-Term, Whole Population Study. The Journal of Urology. 187(1). 48–53. 53 indexed citations
7.
Gudmundsson, Hjalti, et al.. (2010). Incidence and Outcome of Acute Phosphate Nephropathy in Iceland. PLoS ONE. 5(10). e13484–e13484. 14 indexed citations
8.
Harðarson, Sverrir, et al.. (2008). [Renal cell carcinoma diagnosed at autopsy in Iceland 1971-2005].. PubMed. 94(12). 807–12. 4 indexed citations
9.
Jónasson, Friðbert, et al.. (2007). Sveinsson Chorioretinal Atrophy/Helicoid Peripapillary Chorioretinal Degeneration. Ophthalmology. 114(8). 1541–1546. 19 indexed citations
10.
Pálsson, Runólfur, et al.. (2006). Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine. Scandinavian Journal of Urology and Nephrology. 40(6). 522–525. 4 indexed citations
11.
Guðbjartsson, Tómas, Ásgeir Thoroddsen, Vigdís Pétursdóttir, et al.. (2005). Effect of incidental detection for survival of patients with renal cell carcinoma: Results of population-based study of 701 patients. Urology. 66(6). 1186–1191. 81 indexed citations
12.
Guðbjartsson, Tómas, Sverrir Harðarson, Vigdís Pétursdóttir, et al.. (2005). Histological Subtyping and Nuclear Grading of Renal Cell Carcinoma and Their Implications for Survival: A Retrospective Nation-Wide Study of 629 Patients. European Urology. 48(4). 593–600. 157 indexed citations
13.
Guðbjartsson, Tómas, Sverrir Harðarson, Vigdís Pétursdóttir, et al.. (2005). Renal oncocytoma: a clinicopathological analysis of 45 consecutive cases. British Journal of Urology. 96(9). 1275–1279. 47 indexed citations
14.
Guðbjartsson, Tómas, Thora J. Jónasdóttir, Ásgeir Thoroddsen, et al.. (2002). A population‐based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. International Journal of Cancer. 100(4). 476–479. 65 indexed citations
15.
Fisher, Cyril, et al.. (1999). Myxoid variant of follicular dendritic cell sarcoma arising in the breast. Annals of Diagnostic Pathology. 3(2). 92–98. 34 indexed citations
16.
Gunnarsson, Gunnar, et al.. (1999). [Herpes simplex esophagitis in immunocompetent individuals.].. PubMed. 85(3). 211–7. 1 indexed citations
17.
Hjalgrim, Henrik, et al.. (1998). High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands. British Journal of Cancer. 77(7). 1190–1193. 21 indexed citations
18.
Hjalgrim, Henrik, Morten Frisch, ­Eero Pukkala, et al.. (1997). Risk of second cancers in classical Kaposi's sarcoma. International Journal of Cancer. 73(6). 840–843. 17 indexed citations
19.
Harðarson, Sverrir, Mary E. Anderson, & Charles T. Lutz. (1994). Presence of Epstein-Barr Virus in Many Types of Benign and Malignant Lymphoid Lesions. Diagnostic Molecular Pathology. 3(1). 22–31. 11 indexed citations
20.
Hurt, Mark A., Sverrir Harðarson, Miguel J. Stadecker, & Daniel J. Santa Cruz. (1992). Fibroepithelioma‐like changes associated with anogenital epidermotropic mucinous carcinoma. Journal of Cutaneous Pathology. 19(2). 134–141. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walid A. Mourad Breakdown of academic impact, for papers by Stephen Rohan Breakdown of academic impact, for papers by Stela Bulimbašić Breakdown of academic impact, for papers by Chao Cai Breakdown of academic impact, for papers by Masayuki Hagiwara Breakdown of academic impact, for papers by Wen Cai Breakdown of academic impact, for papers by J P Basuyau Breakdown of academic impact, for papers by Yao Liang Breakdown of academic impact, for papers by Claudia Parolini Breakdown of academic impact, for papers by Anita Deshpande
Rankless by CCL
2026